Drug Profile
ABC 48
Alternative Names: ABC-48Latest Information Update: 30 Jun 2017
Price :
$50
*
At a glance
- Originator AERES Biomedical
- Class Monoclonal antibodies
- Mechanism of Action P selectin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 15 Jun 2017 MRC Technology is now called LifeArc
- 21 Mar 2007 Discontinued - Preclinical for Thrombosis in United Kingdom (unspecified route)
- 23 May 2002 Preclinical trials in Thrombosis in United Kingdom (unspecified route)